[throwup238]

> I wonder if that means that the grift is over.

It's just general market conditions. Once interest rates fall, tech VC will go right back to the grift.

Biotech has also seen a major slowdown this year too, despite the huge $43b, $14b, $10.8b, $10b, $8.7b, $7b and $7b [1] acquisitions last year and all the usual IPOs. It's just interest rates catching up to everyone's funds.

[1] Seagen, Karuna Therapeutics, Prometheus Biosciences, Immunogen, Cerevel Therapeutics, Reata Pharmaceuticals, Mirati Therapeutics

[surgical_fire]

I truly hope you are right, otherwise market conditions will only deteriorate further for whoever work in tech.